Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1

Victor DeGruttola, Laurel A Beckett, Robert W. Coombs, Jean Marie Arduino, Henry H. Balfour, Suraiya Rasheed, F. Blaine Hollinger, Margaret A. Fischl, Paul Volberding

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint Dive into the research topics of 'Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1'. Together they form a unique fingerprint.

Medicine & Life Sciences